Effect of cyclic GMP produced by natriuretic peptides on osteoblast-like MC3T3-E1 cells. 1996

T Nashida, and H Matsumoto, and A Imai, and A Kameda, and H Shimomura
Department of Oral Biochemistry, Nippon Dental University School of Dentistry at Niigata, Japan.

The C-type natriuretic peptide (10(-7) M) and atrial natriuretic peptide (10(-7) M) enhanced cGMP accumulation by 418 and 83 times the control value, respectively, in osteoblast-like MC3T3-E1 cells. The natriuretic peptide B receptor was assumed to be the major natriuretic peptide receptor. 8-Bromoguanosine 3',5'-cyclic monophosphate (8-Br-cGMP) activated alkaline phosphatase doubled the activity versus the control value on day 15. Phosphodiesterase activity was not stimulated by the addition of cGMP (1 MicroM). cGMP-dependent protein kinase (G kinase) activity of the supernatant fraction was 25.5 pmol/min/mg protein. The 42 kDa protein band was detected to be phosphorylated by G kinase on SDS-PAGE. These results supported the hypothesis that natriuretic peptides regulate the differentiation of MC3T3-E1 cells through a cGMP-dependent pathway.

UI MeSH Term Description Entries
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D010727 Phosphoric Diester Hydrolases A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4. Phosphodiesterase,Phosphodiesterases,Hydrolases, Phosphoric Diester
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006152 Cyclic GMP Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) Guanosine Cyclic 3',5'-Monophosphate,Guanosine Cyclic 3,5 Monophosphate,Guanosine Cyclic Monophosphate,Guanosine Cyclic-3',5'-Monophosphate,3',5'-Monophosphate, Guanosine Cyclic,Cyclic 3',5'-Monophosphate, Guanosine,Cyclic Monophosphate, Guanosine,Cyclic-3',5'-Monophosphate, Guanosine,GMP, Cyclic,Guanosine Cyclic 3',5' Monophosphate,Monophosphate, Guanosine Cyclic
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D017869 Cyclic GMP-Dependent Protein Kinases A group of cyclic GMP-dependent enzymes that catalyze the phosphorylation of SERINE or THREONINE residues of proteins. Guanosine Cyclic Monophosphate-Dependent Protein Kinase,Guanosine Cyclic Monophosphate-Dependent Protein Kinases,cGMP-Dependent Protein Kinase,cGMP-Dependent Protein Kinases,Cyclic GMP-Dependent Protein Kinase,G-Kinase,G-Kinases,Guanosine Cyclic 3',5'-Phosphate-Dependent Protein Kinase,Protein Kinase G,Cyclic GMP Dependent Protein Kinase,Cyclic GMP Dependent Protein Kinases,G Kinase,G Kinases,Guanosine Cyclic 3',5' Phosphate Dependent Protein Kinase,Guanosine Cyclic Monophosphate Dependent Protein Kinase,Guanosine Cyclic Monophosphate Dependent Protein Kinases,Kinase, cGMP-Dependent Protein,Kinases, cGMP-Dependent Protein,Protein Kinase, cGMP-Dependent,Protein Kinases, cGMP-Dependent,cGMP Dependent Protein Kinase,cGMP Dependent Protein Kinases

Related Publications

T Nashida, and H Matsumoto, and A Imai, and A Kameda, and H Shimomura
May 1998, Calcified tissue international,
T Nashida, and H Matsumoto, and A Imai, and A Kameda, and H Shimomura
October 2020, Molecular medicine reports,
T Nashida, and H Matsumoto, and A Imai, and A Kameda, and H Shimomura
August 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
T Nashida, and H Matsumoto, and A Imai, and A Kameda, and H Shimomura
May 1995, Calcified tissue international,
T Nashida, and H Matsumoto, and A Imai, and A Kameda, and H Shimomura
February 2008, Inflammation,
T Nashida, and H Matsumoto, and A Imai, and A Kameda, and H Shimomura
January 2009, In vivo (Athens, Greece),
T Nashida, and H Matsumoto, and A Imai, and A Kameda, and H Shimomura
August 2003, Biomaterials,
T Nashida, and H Matsumoto, and A Imai, and A Kameda, and H Shimomura
January 1990, Journal of cellular physiology,
T Nashida, and H Matsumoto, and A Imai, and A Kameda, and H Shimomura
August 2006, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
T Nashida, and H Matsumoto, and A Imai, and A Kameda, and H Shimomura
August 2012, Biochemical and biophysical research communications,
Copied contents to your clipboard!